354 related articles for article (PubMed ID: 30301809)
1. mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
Shi G; Ozog S; Torbett BE; Compton AA
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10069-E10078. PubMed ID: 30301809
[TBL] [Abstract][Full Text] [Related]
2. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
Suddala KC; Lee CC; Meraner P; Marin M; Markosyan RM; Desai TM; Cohen FS; Brass AL; Melikyan GB
PLoS Pathog; 2019 Jan; 15(1):e1007532. PubMed ID: 30640957
[TBL] [Abstract][Full Text] [Related]
3. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
Blyth GA; Chan WF; Webster RG; Magor KE
J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
[TBL] [Abstract][Full Text] [Related]
4. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
[TBL] [Abstract][Full Text] [Related]
5. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
[TBL] [Abstract][Full Text] [Related]
6. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
Front Immunol; 2018; 9():228. PubMed ID: 29503647
[TBL] [Abstract][Full Text] [Related]
7. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.
Wrensch F; Winkler M; Pöhlmann S
Viruses; 2014 Sep; 6(9):3683-98. PubMed ID: 25256397
[TBL] [Abstract][Full Text] [Related]
8. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
[TBL] [Abstract][Full Text] [Related]
9. Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry.
Anafu AA; Bowen CH; Chin CR; Brass AL; Holm GH
J Biol Chem; 2013 Jun; 288(24):17261-71. PubMed ID: 23649619
[TBL] [Abstract][Full Text] [Related]
10. Alphavirus Restriction by IFITM Proteins.
Weston S; Czieso S; White IJ; Smith SE; Wash RS; Diaz-Soria C; Kellam P; Marsh M
Traffic; 2016 Sep; 17(9):997-1013. PubMed ID: 27219333
[TBL] [Abstract][Full Text] [Related]
11. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
12. Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.
Appourchaux R; Delpeuch M; Zhong L; Burlaud-Gaillard J; Tartour K; Savidis G; Brass A; Etienne L; Roingeard P; Cimarelli A
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355696
[TBL] [Abstract][Full Text] [Related]
13. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
Narayana SK; Helbig KJ; McCartney EM; Eyre NS; Bull RA; Eltahla A; Lloyd AR; Beard MR
J Biol Chem; 2015 Oct; 290(43):25946-59. PubMed ID: 26354436
[TBL] [Abstract][Full Text] [Related]
14. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Desai TM; Marin M; Chin CR; Savidis G; Brass AL; Melikyan GB
PLoS Pathog; 2014 Apr; 10(4):e1004048. PubMed ID: 24699674
[TBL] [Abstract][Full Text] [Related]
15. IFITM3 requires an amphipathic helix for antiviral activity.
Chesarino NM; Compton AA; McMichael TM; Kenney AD; Zhang L; Soewarna V; Davis M; Schwartz O; Yount JS
EMBO Rep; 2017 Oct; 18(10):1740-1751. PubMed ID: 28835547
[TBL] [Abstract][Full Text] [Related]
16. Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.
Zhang W; Zhang L; Zan Y; Du N; Yang Y; Tien P
J Gen Virol; 2015 Jan; 96(Pt 1):170-182. PubMed ID: 25228491
[TBL] [Abstract][Full Text] [Related]
17. Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay.
Winkler M; Wrensch F; Bosch P; Knoth M; Schindler M; Gärtner S; Pöhlmann S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398796
[TBL] [Abstract][Full Text] [Related]
18. Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction.
Franz S; Pott F; Zillinger T; Schüler C; Dapa S; Fischer C; Passos V; Stenzel S; Chen F; Döhner K; Hartmann G; Sodeik B; Pessler F; Simmons G; Drexler JF; Goffinet C
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34078739
[TBL] [Abstract][Full Text] [Related]
19. Identification of an endocytic signal essential for the antiviral action of IFITM3.
Jia R; Xu F; Qian J; Yao Y; Miao C; Zheng YM; Liu SL; Guo F; Geng Y; Qiao W; Liang C
Cell Microbiol; 2014 Jul; 16(7):1080-93. PubMed ID: 24521078
[TBL] [Abstract][Full Text] [Related]
20. Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunity.
Unali G; Crivicich G; Pagani I; Abou-Alezz M; Folchini F; Valeri E; Matafora V; Reisz JA; Giordano AMS; Cuccovillo I; Butta GM; Donnici L; D'Alessandro A; De Francesco R; Manganaro L; Cittaro D; Merelli I; Petrillo C; Bachi A; Vicenzi E; Kajaste-Rudnitski A
EMBO J; 2023 May; 42(10):e112234. PubMed ID: 36970857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
